Skip to main content

NanoTherics Lands Funding from English Economic Development Agency

NEW YORK (GenomeWeb News) - NanoTherics said today that it has received a grant from Advantage West Midlands that it will use to advance its gene transfection technologies.
 
The Staffordshire, UK-based company was founded in 2007 and is based on technology developed at Keele University and the University of Florida. The company’s technology uses nanoparticles and magnetic fields in the delivery of DNA and other molecules into living cells, which could be used in gene therapy programs.
 
AWM is one of nine regional development agencies in England and it aims to fund programs creating jobs in the West Midlands.
 
The company plans to launch the magnefect-nano, a “flexible device which provides up to 1,000-fold better transfection efficiency than cationic lipid agents for short transfection times,” NanoTherics CEO Linda Cammish said in a statement.
 
NanoTherics did not disclose the amount of the grant from AWM.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.